{"id":"https://openalex.org/W4361890671","doi":"https://doi.org/10.1158/1078-0432.22481808","title":"Supplementary Data from Long-term Follow-up of Patients with Relapsed or Refractory Non\u2013Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human Study","display_name":"Supplementary Data from Long-term Follow-up of Patients with Relapsed or Refractory Non\u2013Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human Study","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361890671","doi":"https://doi.org/10.1158/1078-0432.22481808"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22481808","doi":"https://doi.org/10.1158/1078-0432.22481808","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22481808","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Long-term_Follow-up_of_Patients_with_Relapsed_or_Refractory_Non_Hodgkin_Lymphoma_Treated_with_Venetoclax_in_a_Phase_I_First-in-Human_Study/22481808/1/files/39933321.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Long-term_Follow-up_of_Patients_with_Relapsed_or_Refractory_Non_Hodgkin_Lymphoma_Treated_with_Venetoclax_in_a_Phase_I_First-in-Human_Study/22481808/1/files/39933321.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063755644","display_name":"Matthew Steven Davids","orcid":"https://orcid.org/0000-0003-4529-2003","observed_orcids":["https://orcid.org/0000-0003-4529-2003"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew S. Davids","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033407869","display_name":"Andrew Warwick Roberts","orcid":"https://orcid.org/0000-0002-7341-5720","observed_orcids":["https://orcid.org/0000-0002-7341-5720","https://orcid.org/0000-0001-5347-7169"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew W. Roberts","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7341-5720","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024909755","display_name":"Vaishalee Padgaonkar Kenkre","orcid":"https://orcid.org/0009-0000-4539-9332","observed_orcids":["https://orcid.org/0009-0000-4539-9332"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vaishalee P. Kenkre","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089428686","display_name":"William G. Wierda","orcid":"https://orcid.org/0000-0002-7357-270X","observed_orcids":["https://orcid.org/0000-0002-7357-270X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William G. Wierda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101856702","display_name":"Abhijeet Kumar","orcid":"https://orcid.org/0000-0001-9623-3201","observed_orcids":["https://orcid.org/0000-0001-9623-3201"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abhijeet Kumar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036828560","display_name":"Thomas J. Kipps","orcid":"https://orcid.org/0000-0002-0064-4549","observed_orcids":["https://orcid.org/0000-0002-0064-4549"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas J. Kipps","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077126341","display_name":"Michelle Boyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michelle Boyer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053884536","display_name":"Ahmed Hamed Salem","orcid":"https://orcid.org/0000-0002-9261-1583","observed_orcids":["https://orcid.org/0000-0002-9261-1583"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ahmed Hamed Salem","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9261-1583","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072013221","display_name":"John Carl Pesko","orcid":"https://orcid.org/0000-0002-7568-7762","observed_orcids":["https://orcid.org/0000-0002-7568-7762"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John C. Pesko","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7568-7762","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077181688","display_name":"Jennifer A. Arzt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer A. Arzt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091246313","display_name":"Margaret Mantas","orcid":"https://orcid.org/0000-0003-2829-2757","observed_orcids":["https://orcid.org/0000-0003-2829-2757"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margaret Mantas","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2829-2757","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075160341","display_name":"Su Y. Kim","orcid":"https://orcid.org/0000-0001-8059-0482","observed_orcids":["https://orcid.org/0000-0001-8059-0482"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Su Y. Kim","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8059-0482","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5081326206","display_name":"John Francis Seymour","orcid":"https://orcid.org/0000-0003-2188-6835","observed_orcids":["https://orcid.org/0000-0003-2188-6835"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John F. Seymour","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2188-6835","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.711899995803833,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.711899995803833,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.2736999988555908,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9950000047683716},{"id":"https://openalex.org/keywords/relapsed-or-refractory-non-hodgkin-lymphoma","display_name":"relapsed or refractory non-Hodgkin lymphoma","score":0.9810000061988831},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.9359999895095825},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.7179999947547913}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.8120923042297363},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.7364994287490845},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.649318277835846},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5570510029792786},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5030226111412048},{"id":"https://openalex.org/C2992779791","wikidata":"https://www.wikidata.org/wiki/Q209369","display_name":"Hodgkin lymphoma","level":3,"score":0.4449460506439209},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.399685800075531},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3291964828968048},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.12378299236297607},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09480392932891846},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22481808","doi":"https://doi.org/10.1158/1078-0432.22481808","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22481808","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Long-term_Follow-up_of_Patients_with_Relapsed_or_Refractory_Non_Hodgkin_Lymphoma_Treated_with_Venetoclax_in_a_Phase_I_First-in-Human_Study/22481808/1/files/39933321.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22481808.v1","doi":"https://doi.org/10.1158/1078-0432.22481808.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22481808.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22481808","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Data_from_Long-term_Follow-up_of_Patients_with_Relapsed_or_Refractory_Non_Hodgkin_Lymphoma_Treated_with_Venetoclax_in_a_Phase_I_First-in-Human_Study/22481808","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22481808","doi":"https://doi.org/10.1158/1078-0432.22481808","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22481808","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Long-term_Follow-up_of_Patients_with_Relapsed_or_Refractory_Non_Hodgkin_Lymphoma_Treated_with_Venetoclax_in_a_Phase_I_First-in-Human_Study/22481808/1/files/39933321.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361890671.pdf","grobid_xml":"https://content.openalex.org/works/W4361890671.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3164555487","https://openalex.org/W4361816550","https://openalex.org/W2907545704","https://openalex.org/W2977159719","https://openalex.org/W2892307726","https://openalex.org/W2531109441","https://openalex.org/W2991372896","https://openalex.org/W2273537491","https://openalex.org/W4323535389","https://openalex.org/W2592986981"],"abstract_inverted_index":{"Supplementary":[0],"Data":[1],"from":[2],"Long-term":[3],"Follow-up":[4],"of":[5],"Patients":[6],"with":[7,14],"Relapsed":[8],"or":[9],"Refractory":[10],"Non\u2013Hodgkin":[11],"Lymphoma":[12],"Treated":[13],"Venetoclax":[15],"in":[16],"a":[17],"Phase":[18],"I,":[19],"First-in-Human":[20],"Study":[21]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}